{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:11:06Z","timestamp":1765725066386,"version":"3.48.0"},"reference-count":82,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>For major depression, a one-size-fits-all treatment does not exist. Patients enter a \u2018trial-and-change\u2019 algorithm in which effective therapies are subsequently applied. Unfortunately, an empirically based order of treatments has not yet been determined. There is a magnitude of different treatment strategies while clinical trials only compare a small number of these. Network meta-analyses (NMA) might offer a solution, but so far have been limited in scope and did not account for possible differences in population characteristics that arise with increasing levels of treatment-resistance, potentially violating the transitivity assumption. We; therefore, present a protocol for a systematic review and NMA aiming at summarising and ranking treatments for treatment-resistant depression (TRD) while covering a broad range of therapeutic options and accounting for possible differences in population characteristics at increasing levels of treatment-resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Randomised controlled trials will be included that compared next-step pharmacological, neuromodulation or psychological treatments for treatment-resistant depression (TRD; ie, failure to respond to \u22651 adequate antidepressant drug trial(s) in the current episode) to each other or to a control condition. Primary outcomes will be the proportion of patients who responded to (efficacy) and dropped out of (acceptability) the allocated treatment. A random effects NMA will be conducted, synthesising the evidence for each outcome and determining the differential efficacy of treatments. Heterogeneity in treatment nodes will be reduced by considering alternative geometries of the network structure and by conducting a meta-regression examining different levels of TRD. Local and global methods will be applied to evaluate consistency. The Cochrane Risk of Bias 2 tool, Confidence in Network Meta-Analysis and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework will be used to assess risk of bias and certainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This review does not require ethical approval.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056777","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:30:56Z","timestamp":1650285056000},"page":"e056777","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: protocol for systematic review and network meta-analysis"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-2905","authenticated-orcid":false,"given":"Jan Jacobus","family":"Muit","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip F P","family":"van Eijndhoven","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-8321","authenticated-orcid":false,"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"},{"name":"Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Dalhuisen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"van Bronswijk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, School of Public Health, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henricus G","family":"Ruhe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"2025121407072956000_12.4.e056777.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"2025121407072956000_12.4.e056777.2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.11.1905"},{"key":"2025121407072956000_12.4.e056777.3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev-clinpsy-050817-084746","article-title":"Treatment selection in depression","volume":"14","author":"Cohen","year":"2018","journal-title":"Annu Rev Clin Psychol"},{"key":"2025121407072956000_12.4.e056777.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-010-0160-4"},{"key":"2025121407072956000_12.4.e056777.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2007.03.009"},{"key":"2025121407072956000_12.4.e056777.6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jad.2016.08.019","article-title":"The Dutch measure for quantification of treatment resistance in depression (DM-TRD): an extension of the Maudsley staging method","volume":"205","author":"Peeters","year":"2016","journal-title":"J Affect Disord"},{"key":"2025121407072956000_12.4.e056777.7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2025121407072956000_12.4.e056777.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.02.020"},{"key":"2025121407072956000_12.4.e056777.9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/da.22865","article-title":"Predicting clinical course in major depressive disorder: the association between DM-TRD score and symptom severity over time in 1115 outpatients","volume":"36","author":"van Dijk","year":"2019","journal-title":"Depress Anxiety"},{"key":"2025121407072956000_12.4.e056777.10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.102665"},{"key":"2025121407072956000_12.4.e056777.11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04728"},{"key":"2025121407072956000_12.4.e056777.12","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04309"},{"key":"2025121407072956000_12.4.e056777.13","first-page":"39","article-title":"Treatment-resistant depression: definition and treatment approaches","volume":"51","author":"Nierenberg","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"2025121407072956000_12.4.e056777.14","first-page":"223","article-title":"[The algorithm for the biological treatment of depression in the Dutch multidisciplinary guideline on depression]","volume":"53","author":"Spijker","year":"2011","journal-title":"Tijdschr Psychiatr"},{"key":"2025121407072956000_12.4.e056777.15","unstructured":"NICE . Depression in adults: recognition and management (NICE clinical guidelines No. 90). London: National Institute for Health and Care Excellence (UK), 2009. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553259\/"},{"key":"2025121407072956000_12.4.e056777.16","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0602"},{"key":"2025121407072956000_12.4.e056777.17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13651501.2016.1248852","article-title":"Evidence-based pharmacotherapy of treatment-resistant unipolar depression","volume":"21","author":"Dold","year":"2017","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2025121407072956000_12.4.e056777.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-005-0579-5"},{"key":"2025121407072956000_12.4.e056777.19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","article-title":"Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis","volume":"6","author":"Furukawa","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2025121407072956000_12.4.e056777.20","first-page":"615","article-title":"[Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines]","volume":"52","author":"Ruh\u00e9","year":"2010","journal-title":"Tijdschr Psychiatr"},{"key":"2025121407072956000_12.4.e056777.21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-018-1096-5","article-title":"Optimising first- and second-line treatment strategies for untreated major depressive disorder - the SUN\u263aD study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial","volume":"16","author":"Kato","year":"2018","journal-title":"BMC Med"},{"key":"2025121407072956000_12.4.e056777.22","doi-asserted-by":"publisher","DOI":"10.1177\/070674371005500303"},{"key":"2025121407072956000_12.4.e056777.23","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.3.327"},{"key":"2025121407072956000_12.4.e056777.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052963"},{"key":"2025121407072956000_12.4.e056777.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.08.010"},{"key":"2025121407072956000_12.4.e056777.26","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv060"},{"key":"2025121407072956000_12.4.e056777.27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14r09204"},{"key":"2025121407072956000_12.4.e056777.28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/03007995.2016.1277201","article-title":"Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis","volume":"33","author":"Papadimitropoulou","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"2025121407072956000_12.4.e056777.29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/09540261.2020.1765748","article-title":"Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis","volume":"32","author":"Carter","year":"2020","journal-title":"Int Rev Psychiatry"},{"key":"2025121407072956000_12.4.e056777.30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","article-title":"Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials","volume":"287","author":"Li","year":"2021","journal-title":"J Affect Disord"},{"key":"2025121407072956000_12.4.e056777.31","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv023"},{"key":"2025121407072956000_12.4.e056777.32","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"2025121407072956000_12.4.e056777.33","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2025121407072956000_12.4.e056777.34","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"2025121407072956000_12.4.e056777.35","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1162-5"},{"key":"2025121407072956000_12.4.e056777.36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jclinepi.2020.12.012","article-title":"Different control conditions can produce different effect estimates in psychotherapy trials for depression","volume":"132","author":"Michopoulos","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2025121407072956000_12.4.e056777.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010919"},{"key":"2025121407072956000_12.4.e056777.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.03.009"},{"key":"2025121407072956000_12.4.e056777.39","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06419"},{"key":"2025121407072956000_12.4.e056777.40","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.734"},{"key":"2025121407072956000_12.4.e056777.41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ph3010019","article-title":"The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments","volume":"3","author":"Machado-Vieira","year":"2010","journal-title":"Pharmaceuticals"},{"key":"2025121407072956000_12.4.e056777.42","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071068"},{"key":"2025121407072956000_12.4.e056777.43","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320921694","article-title":"How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding","volume":"10","author":"Hengartner","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025121407072956000_12.4.e056777.44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10503307.2019.1566676","article-title":"The dose-response effect in routinely delivered psychological therapies: a systematic review","volume":"30","author":"Robinson","year":"2020","journal-title":"Psychother Res"},{"key":"2025121407072956000_12.4.e056777.45","article-title":"Pharmacological interventions for treatment-resistant depression in adults","volume":"12","author":"Davies","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121407072956000_12.4.e056777.46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S003329171800199X","article-title":"Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression","volume":"49","author":"van Bronswijk","year":"2019","journal-title":"Psychol Med"},{"key":"2025121407072956000_12.4.e056777.47","article-title":"Psychological therapies for treatment-resistant depression in adults","volume":"5","author":"Ijaz","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121407072956000_12.4.e056777.48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2020.11.006","article-title":"Augmentation with atypical antipsychotics for treatment-resistant depression","volume":"280","author":"Cant\u00f9","year":"2021","journal-title":"J Affect Disord"},{"key":"2025121407072956000_12.4.e056777.49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001052","article-title":"Treatment of adults with treatment-resistant depression: electroconvulsive therapy plus antidepressant or electroconvulsive therapy alone? Evidence from an indirect comparison meta-analysis","volume":"94","author":"Song","year":"2015","journal-title":"Medicine"},{"key":"2025121407072956000_12.4.e056777.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2019.152156"},{"key":"2025121407072956000_12.4.e056777.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.11.012"},{"key":"2025121407072956000_12.4.e056777.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1079"},{"key":"2025121407072956000_12.4.e056777.53","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2025121407072956000_12.4.e056777.54","unstructured":"Higgins JPT , Thomas J , Chandler J . Cochrane handbook for systematic reviews of interventions 2021 [version 6.2 (updated February 2021). Available: www.training.cochrane.org\/handbook"},{"key":"2025121407072956000_12.4.e056777.55","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117"},{"key":"2025121407072956000_12.4.e056777.56","unstructured":"R\u00fccker G , Krahn U , K\u00f6nig J . netmeta: network meta-analysis using Frequentist methods, 2021."},{"key":"2025121407072956000_12.4.e056777.57","unstructured":"R Core Team . R: a language and environment for statistical computing. Vienna, Austria, 2021."},{"key":"2025121407072956000_12.4.e056777.58","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1347"},{"key":"2025121407072956000_12.4.e056777.59","unstructured":"Doi SA , Furuya-Kanamori L , Xu C . Questionable utility of the relative risk in clinical research: a call for change to practice. J Clin Epidemiol 2020."},{"key":"2025121407072956000_12.4.e056777.60","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025121407072956000_12.4.e056777.61","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6381"},{"key":"2025121407072956000_12.4.e056777.62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121407072956000_12.4.e056777.63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39343.408449.80"},{"key":"2025121407072956000_12.4.e056777.64","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12343"},{"key":"2025121407072956000_12.4.e056777.65","article-title":"Pharmacological treatment for psychotic depression","volume":"7","author":"Wijkstra","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121407072956000_12.4.e056777.66","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1943"},{"key":"2025121407072956000_12.4.e056777.67","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.2044"},{"key":"2025121407072956000_12.4.e056777.68","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.2045"},{"key":"2025121407072956000_12.4.e056777.69","doi-asserted-by":"publisher","DOI":"10.1159\/000209348"},{"key":"2025121407072956000_12.4.e056777.70","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08r04516blu"},{"key":"2025121407072956000_12.4.e056777.71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099682"},{"key":"2025121407072956000_12.4.e056777.72","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767"},{"key":"2025121407072956000_12.4.e056777.73","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"2025121407072956000_12.4.e056777.74","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6188"},{"key":"2025121407072956000_12.4.e056777.75","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-106"},{"key":"2025121407072956000_12.4.e056777.76","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys222"},{"key":"2025121407072956000_12.4.e056777.77","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-016-2019-1","article-title":"Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review","volume":"9","author":"Furukawa","year":"2016","journal-title":"BMC Res Notes"},{"key":"2025121407072956000_12.4.e056777.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.010"},{"key":"2025121407072956000_12.4.e056777.79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Res Synth Methods"},{"key":"2025121407072956000_12.4.e056777.80","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.60.5.664"},{"key":"2025121407072956000_12.4.e056777.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.08.009"},{"key":"2025121407072956000_12.4.e056777.82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:07:53Z","timestamp":1765724873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,18]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-056777"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056777","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}